nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Prednisolone—hematologic cancer	0.196	1	CrCtD
Progesterone—SLC22A1—hematologic cancer	0.0514	0.289	CbGaD
Progesterone—AR—hematologic cancer	0.0457	0.256	CbGaD
Progesterone—ESR1—hematologic cancer	0.0352	0.197	CbGaD
Progesterone—NR3C1—hematologic cancer	0.031	0.174	CbGaD
Progesterone—ABCB1—hematologic cancer	0.015	0.0839	CbGaD
Progesterone—CYP1B1—Procarbazine—hematologic cancer	0.0126	0.0428	CbGbCtD
Progesterone—SLC22A3—Melphalan—hematologic cancer	0.0104	0.0353	CbGbCtD
Progesterone—NR3C2—Betamethasone—hematologic cancer	0.00815	0.0277	CbGbCtD
Progesterone—NR3C2—Prednisolone—hematologic cancer	0.00804	0.0274	CbGbCtD
Progesterone—Potassium Canrenoate—Prednisone—hematologic cancer	0.0075	0.0445	CrCrCtD
Progesterone—Potassium Canrenoate—Prednisolone—hematologic cancer	0.00732	0.0434	CrCrCtD
Progesterone—ABCC1—Idarubicin—hematologic cancer	0.00677	0.023	CbGbCtD
Progesterone—ABCB11—Daunorubicin—hematologic cancer	0.00675	0.023	CbGbCtD
Progesterone—CYP1B1—Daunorubicin—hematologic cancer	0.00675	0.023	CbGbCtD
Progesterone—Danazol—Prednisone—hematologic cancer	0.00634	0.0375	CrCrCtD
Progesterone—Medrysone—Prednisolone—hematologic cancer	0.00619	0.0366	CrCrCtD
Progesterone—Testolactone—Betamethasone—hematologic cancer	0.00559	0.0331	CrCrCtD
Progesterone—Testolactone—Dexamethasone—hematologic cancer	0.00559	0.0331	CrCrCtD
Progesterone—Hydrocortamate—Prednisone—hematologic cancer	0.00551	0.0327	CrCrCtD
Progesterone—Testolactone—Triamcinolone—hematologic cancer	0.00546	0.0324	CrCrCtD
Progesterone—Hydrocortamate—Prednisolone—hematologic cancer	0.00538	0.0319	CrCrCtD
Progesterone—Cortisone acetate—Prednisone—hematologic cancer	0.00534	0.0316	CrCrCtD
Progesterone—PGR—Betamethasone—hematologic cancer	0.00527	0.0179	CbGbCtD
Progesterone—Cortisone acetate—Prednisolone—hematologic cancer	0.00521	0.0309	CrCrCtD
Progesterone—Testolactone—Prednisone—hematologic cancer	0.00518	0.0307	CrCrCtD
Progesterone—Fluoxymesterone—Betamethasone—hematologic cancer	0.00514	0.0304	CrCrCtD
Progesterone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00514	0.0304	CrCrCtD
Progesterone—Testolactone—Prednisolone—hematologic cancer	0.00506	0.03	CrCrCtD
Progesterone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00502	0.0297	CrCrCtD
Progesterone—Fludrocortisone—Dexamethasone—hematologic cancer	0.005	0.0296	CrCrCtD
Progesterone—Fludrocortisone—Betamethasone—hematologic cancer	0.005	0.0296	CrCrCtD
Progesterone—Fludrocortisone—Triamcinolone—hematologic cancer	0.00489	0.029	CrCrCtD
Progesterone—ABCC1—Daunorubicin—hematologic cancer	0.00479	0.0163	CbGbCtD
Progesterone—NR3C2—Dexamethasone—hematologic cancer	0.00474	0.0161	CbGbCtD
Progesterone—Fluoxymesterone—Prednisolone—hematologic cancer	0.00465	0.0275	CrCrCtD
Progesterone—Fludrocortisone—Prednisone—hematologic cancer	0.00464	0.0275	CrCrCtD
Progesterone—Fludrocortisone—Prednisolone—hematologic cancer	0.00453	0.0268	CrCrCtD
Progesterone—Methyltestosterone—Prednisone—hematologic cancer	0.00452	0.0268	CrCrCtD
Progesterone—CYP17A1—Dexamethasone—hematologic cancer	0.00442	0.015	CbGbCtD
Progesterone—Methyltestosterone—Prednisolone—hematologic cancer	0.00442	0.0262	CrCrCtD
Progesterone—SLC22A2—Daunorubicin—hematologic cancer	0.00434	0.0148	CbGbCtD
Progesterone—Prednisolone—Dexamethasone—hematologic cancer	0.00425	0.0252	CrCrCtD
Progesterone—Prednisolone—Betamethasone—hematologic cancer	0.00425	0.0252	CrCrCtD
Progesterone—Prednisolone—Triamcinolone—hematologic cancer	0.00415	0.0246	CrCrCtD
Progesterone—CYP1B1—Dasatinib—hematologic cancer	0.00415	0.0141	CbGbCtD
Progesterone—CYP1B1—Mitoxantrone—hematologic cancer	0.0041	0.0139	CbGbCtD
Progesterone—Hydrocortisone—Betamethasone—hematologic cancer	0.00408	0.0242	CrCrCtD
Progesterone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00408	0.0242	CrCrCtD
Progesterone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00399	0.0236	CrCrCtD
Progesterone—CYP17A1—ovarian follicle—hematologic cancer	0.00395	0.164	CbGeAlD
Progesterone—Prednisolone—Prednisone—hematologic cancer	0.00394	0.0234	CrCrCtD
Progesterone—Testosterone—Prednisolone—hematologic cancer	0.00393	0.0233	CrCrCtD
Progesterone—SLC22A2—Cytarabine—hematologic cancer	0.00383	0.013	CbGbCtD
Progesterone—CYP2A6—Methoxsalen—hematologic cancer	0.00381	0.013	CbGbCtD
Progesterone—Hydrocortisone—Prednisone—hematologic cancer	0.00378	0.0224	CrCrCtD
Progesterone—Hydrocortisone—Prednisolone—hematologic cancer	0.00369	0.0219	CrCrCtD
Progesterone—SLC22A2—Cladribine—hematologic cancer	0.00362	0.0123	CbGbCtD
Progesterone—SLC22A3—Irinotecan—hematologic cancer	0.00351	0.0119	CbGbCtD
Progesterone—SLC22A1—Cytarabine—hematologic cancer	0.00333	0.0113	CbGbCtD
Progesterone—SLC22A2—Imatinib—hematologic cancer	0.00333	0.0113	CbGbCtD
Progesterone—CYP1A2—Anagrelide—hematologic cancer	0.00325	0.0111	CbGbCtD
Progesterone—CYP1A1—Methoxsalen—hematologic cancer	0.00325	0.0111	CbGbCtD
Progesterone—SLC22A1—Cladribine—hematologic cancer	0.00314	0.0107	CbGbCtD
Progesterone—NR3C1—Triamcinolone—hematologic cancer	0.00313	0.0107	CbGbCtD
Progesterone—CYP1A1—Bortezomib—hematologic cancer	0.00309	0.0105	CbGbCtD
Progesterone—SLC22A3—Vincristine—hematologic cancer	0.00307	0.0104	CbGbCtD
Progesterone—PGR—Dexamethasone—hematologic cancer	0.00306	0.0104	CbGbCtD
Progesterone—CYP1A1—Daunorubicin—hematologic cancer	0.00296	0.0101	CbGbCtD
Progesterone—ABCC1—Mitoxantrone—hematologic cancer	0.00291	0.00991	CbGbCtD
Progesterone—SLC22A1—Imatinib—hematologic cancer	0.00289	0.00984	CbGbCtD
Progesterone—ABCB11—Vinblastine—hematologic cancer	0.00287	0.00976	CbGbCtD
Progesterone—ABCB11—Vincristine—hematologic cancer	0.00282	0.0096	CbGbCtD
Progesterone—CYP2A6—Ifosfamide—hematologic cancer	0.00278	0.00945	CbGbCtD
Progesterone—CYP1A1—Thalidomide—hematologic cancer	0.0027	0.00917	CbGbCtD
Progesterone—NR3C1—Betamethasone—hematologic cancer	0.00269	0.00915	CbGbCtD
Progesterone—NR3C1—Prednisolone—hematologic cancer	0.00265	0.00903	CbGbCtD
Progesterone—PGR—ovarian follicle—hematologic cancer	0.00265	0.11	CbGeAlD
Progesterone—NR3C1—Prednisone—hematologic cancer	0.00251	0.00853	CbGbCtD
Progesterone—ABCC1—Epirubicin—hematologic cancer	0.00236	0.00802	CbGbCtD
Progesterone—CYP1A1—Dacarbazine—hematologic cancer	0.00232	0.00789	CbGbCtD
Progesterone—ABCC1—Irinotecan—hematologic cancer	0.00229	0.0078	CbGbCtD
Progesterone—CYP1B1—Dexamethasone—hematologic cancer	0.00213	0.00723	CbGbCtD
Progesterone—ABCB11—Dexamethasone—hematologic cancer	0.00213	0.00723	CbGbCtD
Progesterone—ESR1—ovarian follicle—hematologic cancer	0.00207	0.0864	CbGeAlD
Progesterone—ABCC1—Vinblastine—hematologic cancer	0.00204	0.00693	CbGbCtD
Progesterone—CYP2C9—Bexarotene—hematologic cancer	0.00203	0.00691	CbGbCtD
Progesterone—ABCC1—Vincristine—hematologic cancer	0.002	0.00682	CbGbCtD
Progesterone—ABCB1—Lenalidomide—hematologic cancer	0.00197	0.00671	CbGbCtD
Progesterone—CYP3A7—Ifosfamide—hematologic cancer	0.0019	0.00646	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0019	0.00646	CbGbCtD
Progesterone—CYP2A6—Prednisolone—hematologic cancer	0.00185	0.0063	CbGbCtD
Progesterone—SLC22A2—Vinblastine—hematologic cancer	0.00185	0.00629	CbGbCtD
Progesterone—ABCC1—Etoposide—hematologic cancer	0.00184	0.00625	CbGbCtD
Progesterone—CYP1A1—Dasatinib—hematologic cancer	0.00182	0.0062	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00181	0.00617	CbGbCtD
Progesterone—CYP3A7—Imatinib—hematologic cancer	0.00181	0.00617	CbGbCtD
Progesterone—CYP2C8—Bortezomib—hematologic cancer	0.00179	0.00608	CbGbCtD
Progesterone—CYP3A5—Daunorubicin—hematologic cancer	0.00178	0.00604	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—hematologic cancer	0.00176	0.006	CbGbCtD
Progesterone—ABCB11—Doxorubicin—hematologic cancer	0.00176	0.006	CbGbCtD
Progesterone—CYP2D6—Lomustine—hematologic cancer	0.00173	0.00588	CbGbCtD
Progesterone—CYP1A2—Carmustine—hematologic cancer	0.00171	0.00582	CbGbCtD
Progesterone—SLC22A2—Cisplatin—hematologic cancer	0.00169	0.00576	CbGbCtD
Progesterone—CYP2C9—Idarubicin—hematologic cancer	0.00168	0.00573	CbGbCtD
Progesterone—CYP3A5—Thalidomide—hematologic cancer	0.00162	0.00551	CbGbCtD
Progesterone—NR3C1—Dexamethasone—hematologic cancer	0.00156	0.00532	CbGbCtD
Progesterone—CYP3A5—Teniposide—hematologic cancer	0.00154	0.00525	CbGbCtD
Progesterone—CYP2D6—Idarubicin—hematologic cancer	0.00154	0.00524	CbGbCtD
Progesterone—CYP2C19—Bortezomib—hematologic cancer	0.0015	0.0051	CbGbCtD
Progesterone—CYP1A2—Methoxsalen—hematologic cancer	0.00145	0.00494	CbGbCtD
Progesterone—CYP3A5—Ifosfamide—hematologic cancer	0.00142	0.00485	CbGbCtD
Progesterone—CYP1A2—Bortezomib—hematologic cancer	0.00138	0.0047	CbGbCtD
Progesterone—CYP2C8—Ifosfamide—hematologic cancer	0.00137	0.00466	CbGbCtD
Progesterone—CYP3A5—Imatinib—hematologic cancer	0.00136	0.00463	CbGbCtD
Progesterone—CYP1A2—Daunorubicin—hematologic cancer	0.00132	0.0045	CbGbCtD
Progesterone—CYP2D6—Hydroxyurea—hematologic cancer	0.00131	0.00445	CbGbCtD
Progesterone—CYP2C19—Thalidomide—hematologic cancer	0.00131	0.00444	CbGbCtD
Progesterone—CYP1A2—Alitretinoin—hematologic cancer	0.0013	0.00441	CbGbCtD
Progesterone—ABCC1—Doxorubicin—hematologic cancer	0.00125	0.00426	CbGbCtD
Progesterone—CYP2C9—Bortezomib—hematologic cancer	0.00125	0.00424	CbGbCtD
Progesterone—CYP2C19—Teniposide—hematologic cancer	0.00125	0.00424	CbGbCtD
Progesterone—ABCC1—Methotrexate—hematologic cancer	0.00121	0.00413	CbGbCtD
Progesterone—CYP1A2—Thalidomide—hematologic cancer	0.0012	0.0041	CbGbCtD
Progesterone—CYP2C8—Nilotinib—hematologic cancer	0.00119	0.00405	CbGbCtD
Progesterone—CYP3A4—Bexarotene—hematologic cancer	0.00118	0.00402	CbGbCtD
Progesterone—ABCB1—Daunorubicin—hematologic cancer	0.00116	0.00393	CbGbCtD
Progesterone—CYP2C19—Ifosfamide—hematologic cancer	0.00115	0.00391	CbGbCtD
Progesterone—CYP2D6—Bortezomib—hematologic cancer	0.00114	0.00388	CbGbCtD
Progesterone—CYP3A7—Irinotecan—hematologic cancer	0.00113	0.00386	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00113	0.00386	CbGbCtD
Progesterone—ABCB1—Alitretinoin—hematologic cancer	0.00113	0.00385	CbGbCtD
Progesterone—CYP3A4—Lomustine—hematologic cancer	0.0011	0.00374	CbGbCtD
Progesterone—CYP3A4—Busulfan—hematologic cancer	0.0011	0.00374	CbGbCtD
Progesterone—CYP2C19—Imatinib—hematologic cancer	0.0011	0.00373	CbGbCtD
Progesterone—CYP3A5—Dasatinib—hematologic cancer	0.00109	0.00372	CbGbCtD
Progesterone—CYP2A6—Dexamethasone—hematologic cancer	0.00109	0.00371	CbGbCtD
Progesterone—CYP2C9—Thalidomide—hematologic cancer	0.00109	0.00369	CbGbCtD
Progesterone—CYP1A2—Dacarbazine—hematologic cancer	0.00104	0.00352	CbGbCtD
Progesterone—CYP2C9—Teniposide—hematologic cancer	0.00104	0.00352	CbGbCtD
Progesterone—CYP1A2—Imatinib—hematologic cancer	0.00101	0.00345	CbGbCtD
Progesterone—CYP3A7—Vincristine—hematologic cancer	0.00099	0.00337	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00099	0.00337	CbGbCtD
Progesterone—CYP3A4—Thiotepa—hematologic cancer	0.000979	0.00333	CbGbCtD
Progesterone—CYP2C9—Ifosfamide—hematologic cancer	0.000955	0.00325	CbGbCtD
Progesterone—CYP1A1—Dexamethasone—hematologic cancer	0.000933	0.00317	CbGbCtD
Progesterone—CYP2C9—Imatinib—hematologic cancer	0.000913	0.0031	CbGbCtD
Progesterone—ABCB1—Imatinib—hematologic cancer	0.000886	0.00301	CbGbCtD
Progesterone—CYP3A5—Irinotecan—hematologic cancer	0.00085	0.00289	CbGbCtD
Progesterone—CYP2D6—Imatinib—hematologic cancer	0.000835	0.00284	CbGbCtD
Progesterone—CYP2C9—Nilotinib—hematologic cancer	0.000829	0.00282	CbGbCtD
Progesterone—CYP1A2—Dasatinib—hematologic cancer	0.000814	0.00277	CbGbCtD
Progesterone—ABCB1—Nilotinib—hematologic cancer	0.000805	0.00274	CbGbCtD
Progesterone—ABCB1—Vinorelbine—hematologic cancer	0.000798	0.00272	CbGbCtD
Progesterone—CYP3A4—Methoxsalen—hematologic cancer	0.000762	0.00259	CbGbCtD
Progesterone—CYP2D6—Nilotinib—hematologic cancer	0.000758	0.00258	CbGbCtD
Progesterone—CYP2D6—Vinorelbine—hematologic cancer	0.000752	0.00256	CbGbCtD
Progesterone—CYP3A7—Dexamethasone—hematologic cancer	0.000746	0.00254	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.000746	0.00254	CbGbCtD
Progesterone—CYP3A5—Vincristine—hematologic cancer	0.000743	0.00253	CbGbCtD
Progesterone—CYP3A4—Bortezomib—hematologic cancer	0.000724	0.00246	CbGbCtD
Progesterone—CYP2C19—Prednisone—hematologic cancer	0.000723	0.00246	CbGbCtD
Progesterone—ABCB1—Dasatinib—hematologic cancer	0.000711	0.00242	CbGbCtD
Progesterone—ABCB1—Mitoxantrone—hematologic cancer	0.000703	0.00239	CbGbCtD
Progesterone—CYP3A4—Daunorubicin—hematologic cancer	0.000693	0.00236	CbGbCtD
Progesterone—CYP3A5—Etoposide—hematologic cancer	0.000681	0.00232	CbGbCtD
Progesterone—CYP2C8—Etoposide—hematologic cancer	0.000655	0.00223	CbGbCtD
Progesterone—ABCB1—Betamethasone—hematologic cancer	0.000626	0.00213	CbGbCtD
Progesterone—ABCB1—Gemcitabine—hematologic cancer	0.000621	0.00211	CbGbCtD
Progesterone—ABCB1—Prednisolone—hematologic cancer	0.000618	0.0021	CbGbCtD
Progesterone—CYP3A4—Cytarabine—hematologic cancer	0.000611	0.00208	CbGbCtD
Progesterone—CYP3A4—Teniposide—hematologic cancer	0.000602	0.00205	CbGbCtD
Progesterone—ABCB1—Prednisone—hematologic cancer	0.000584	0.00199	CbGbCtD
Progesterone—CYP3A5—Dexamethasone—hematologic cancer	0.00056	0.0019	CbGbCtD
Progesterone—CYP3A4—Ifosfamide—hematologic cancer	0.000556	0.00189	CbGbCtD
Progesterone—ABCB1—Irinotecan—hematologic cancer	0.000553	0.00188	CbGbCtD
Progesterone—CYP2C8—Dexamethasone—hematologic cancer	0.000538	0.00183	CbGbCtD
Progesterone—CYP3A4—Imatinib—hematologic cancer	0.000531	0.00181	CbGbCtD
Progesterone—CYP1A2—Etoposide—hematologic cancer	0.000507	0.00172	CbGbCtD
Progesterone—CYP3A4—Ruxolitinib—hematologic cancer	0.0005	0.0017	CbGbCtD
Progesterone—ABCB1—Vinblastine—hematologic cancer	0.000492	0.00167	CbGbCtD
Progesterone—ABCB1—Vincristine—hematologic cancer	0.000484	0.00165	CbGbCtD
Progesterone—CYP3A4—Nilotinib—hematologic cancer	0.000482	0.00164	CbGbCtD
Progesterone—CYP3A4—Vinorelbine—hematologic cancer	0.000478	0.00163	CbGbCtD
Progesterone—CYP2C9—Cisplatin—hematologic cancer	0.000465	0.00158	CbGbCtD
Progesterone—CYP2D6—Vinblastine—hematologic cancer	0.000463	0.00158	CbGbCtD
Progesterone—CYP2C19—Dexamethasone—hematologic cancer	0.000452	0.00154	CbGbCtD
Progesterone—ABCB1—Cisplatin—hematologic cancer	0.000451	0.00153	CbGbCtD
Progesterone—ABCB1—Etoposide—hematologic cancer	0.000443	0.00151	CbGbCtD
Progesterone—CYP3A4—Triamcinolone—hematologic cancer	0.000437	0.00149	CbGbCtD
Progesterone—CYP3A4—Dasatinib—hematologic cancer	0.000426	0.00145	CbGbCtD
Progesterone—CYP3A4—Mitoxantrone—hematologic cancer	0.000421	0.00143	CbGbCtD
Progesterone—SLC10A1—gonad—hematologic cancer	0.000416	0.0173	CbGeAlD
Progesterone—CYP2C9—Dexamethasone—hematologic cancer	0.000375	0.00128	CbGbCtD
Progesterone—CYP3A4—Betamethasone—hematologic cancer	0.000375	0.00128	CbGbCtD
Progesterone—CYP3A4—Prednisolone—hematologic cancer	0.00037	0.00126	CbGbCtD
Progesterone—ABCB1—Dexamethasone—hematologic cancer	0.000364	0.00124	CbGbCtD
Progesterone—CYP17A1—gonad—hematologic cancer	0.000362	0.0151	CbGeAlD
Progesterone—SHBG—hematopoietic system—hematologic cancer	0.000355	0.0148	CbGeAlD
Progesterone—CYP3A4—Prednisone—hematologic cancer	0.00035	0.00119	CbGbCtD
Progesterone—NR3C2—hematopoietic system—hematologic cancer	0.000344	0.0143	CbGeAlD
Progesterone—CYP2D6—Dexamethasone—hematologic cancer	0.000343	0.00117	CbGbCtD
Progesterone—CYP3A4—Irinotecan—hematologic cancer	0.000331	0.00113	CbGbCtD
Progesterone—PGR—hematopoietic system—hematologic cancer	0.00032	0.0133	CbGeAlD
Progesterone—ABCB1—Doxorubicin—hematologic cancer	0.000302	0.00103	CbGbCtD
Progesterone—SLC10A1—testis—hematologic cancer	0.0003	0.0125	CbGeAlD
Progesterone—ABCB11—testis—hematologic cancer	0.000296	0.0123	CbGeAlD
Progesterone—CYP3A4—Vinblastine—hematologic cancer	0.000295	0.001	CbGbCtD
Progesterone—SLC22A3—hematopoietic system—hematologic cancer	0.000293	0.0122	CbGeAlD
Progesterone—ABCB1—Methotrexate—hematologic cancer	0.000293	0.000996	CbGbCtD
Progesterone—CYP3A4—Vincristine—hematologic cancer	0.00029	0.000986	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—hematologic cancer	0.000285	0.000969	CbGbCtD
Progesterone—SHBG—gonad—hematologic cancer	0.00027	0.0112	CbGeAlD
Progesterone—CYP1B1—hematopoietic system—hematologic cancer	0.000269	0.0112	CbGeAlD
Progesterone—CYP3A4—Etoposide—hematologic cancer	0.000265	0.000903	CbGbCtD
Progesterone—CYP17A1—testis—hematologic cancer	0.000261	0.0109	CbGeAlD
Progesterone—AR—hematopoietic system—hematologic cancer	0.000255	0.0106	CbGeAlD
Progesterone—ESR1—hematopoietic system—hematologic cancer	0.00025	0.0104	CbGeAlD
Progesterone—CYP2C19—hematopoietic system—hematologic cancer	0.000236	0.00984	CbGeAlD
Progesterone—SHBG—blood—hematologic cancer	0.000235	0.0098	CbGeAlD
Progesterone—NR3C2—blood—hematologic cancer	0.000228	0.0095	CbGeAlD
Progesterone—SHBG—bone marrow—hematologic cancer	0.000228	0.00949	CbGeAlD
Progesterone—SLC22A3—gonad—hematologic cancer	0.000223	0.00928	CbGeAlD
Progesterone—CYP3A4—Dexamethasone—hematologic cancer	0.000218	0.000743	CbGbCtD
Progesterone—CYP2A6—lung—hematologic cancer	0.000213	0.00888	CbGeAlD
Progesterone—PGR—blood—hematologic cancer	0.000212	0.00883	CbGeAlD
Progesterone—CYP2C8—hematopoietic system—hematologic cancer	0.000206	0.00859	CbGeAlD
Progesterone—CYP1B1—gonad—hematologic cancer	0.000205	0.00853	CbGeAlD
Progesterone—SLC22A1—blood—hematologic cancer	0.000203	0.00846	CbGeAlD
Progesterone—NR3C2—lung—hematologic cancer	0.0002	0.00833	CbGeAlD
Progesterone—SHBG—testis—hematologic cancer	0.000195	0.00811	CbGeAlD
Progesterone—AR—gonad—hematologic cancer	0.000194	0.00807	CbGeAlD
Progesterone—CYP1A2—hematopoietic system—hematologic cancer	0.000193	0.00804	CbGeAlD
Progesterone—CYP1A1—hematopoietic system—hematologic cancer	0.00019	0.00793	CbGeAlD
Progesterone—ESR1—gonad—hematologic cancer	0.00019	0.00793	CbGeAlD
Progesterone—CYP17A1—lymph node—hematologic cancer	0.000189	0.00788	CbGeAlD
Progesterone—NR3C2—testis—hematologic cancer	0.000189	0.00786	CbGeAlD
Progesterone—SIGMAR1—blood—hematologic cancer	0.000188	0.00781	CbGeAlD
Progesterone—CYP3A5—hematopoietic system—hematologic cancer	0.000186	0.00775	CbGeAlD
Progesterone—PGR—lung—hematologic cancer	0.000186	0.00774	CbGeAlD
Progesterone—NR3C1—hematopoietic system—hematologic cancer	0.000185	0.00769	CbGeAlD
Progesterone—CYP2C9—hematopoietic system—hematologic cancer	0.000183	0.00763	CbGeAlD
Progesterone—SIGMAR1—bone marrow—hematologic cancer	0.000181	0.00756	CbGeAlD
Progesterone—CYP3A4—Doxorubicin—hematologic cancer	0.000181	0.000616	CbGbCtD
Progesterone—CYP1B1—blood—hematologic cancer	0.000178	0.00743	CbGeAlD
Progesterone—PGR—testis—hematologic cancer	0.000175	0.0073	CbGeAlD
Progesterone—SLC22A3—lung—hematologic cancer	0.00017	0.00709	CbGeAlD
Progesterone—AR—blood—hematologic cancer	0.000169	0.00704	CbGeAlD
Progesterone—ESR1—blood—hematologic cancer	0.000166	0.00691	CbGeAlD
Progesterone—SIGMAR1—lung—hematologic cancer	0.000164	0.00685	CbGeAlD
Progesterone—SLC22A3—testis—hematologic cancer	0.00016	0.00669	CbGeAlD
Progesterone—ABCC1—blood—hematologic cancer	0.00016	0.00668	CbGeAlD
Progesterone—CYP2C19—blood—hematologic cancer	0.000156	0.00652	CbGeAlD
Progesterone—CYP1B1—lung—hematologic cancer	0.000156	0.00651	CbGeAlD
Progesterone—SIGMAR1—testis—hematologic cancer	0.000155	0.00646	CbGeAlD
Progesterone—AR—lung—hematologic cancer	0.000148	0.00617	CbGeAlD
Progesterone—CYP1B1—testis—hematologic cancer	0.000148	0.00614	CbGeAlD
Progesterone—ESR1—lung—hematologic cancer	0.000145	0.00605	CbGeAlD
Progesterone—ABCC1—lung—hematologic cancer	0.000141	0.00586	CbGeAlD
Progesterone—NR3C1—gonad—hematologic cancer	0.00014	0.00585	CbGeAlD
Progesterone—AR—testis—hematologic cancer	0.00014	0.00582	CbGeAlD
Progesterone—CYP3A4—hematopoietic system—hematologic cancer	0.00014	0.00582	CbGeAlD
Progesterone—CYP2D6—hematopoietic system—hematologic cancer	0.000137	0.00572	CbGeAlD
Progesterone—ESR1—testis—hematologic cancer	0.000137	0.00571	CbGeAlD
Progesterone—NR3C2—lymph node—hematologic cancer	0.000137	0.0057	CbGeAlD
Progesterone—CYP2C8—blood—hematologic cancer	0.000137	0.00569	CbGeAlD
Progesterone—ABCC1—testis—hematologic cancer	0.000133	0.00553	CbGeAlD
Progesterone—Stanozolol—AR—hematologic cancer	0.000129	0.0687	CrCbGaD
Progesterone—CYP1A2—blood—hematologic cancer	0.000128	0.00532	CbGeAlD
Progesterone—PGR—lymph node—hematologic cancer	0.000127	0.00529	CbGeAlD
Progesterone—CYP1A1—blood—hematologic cancer	0.000126	0.00525	CbGeAlD
Progesterone—CYP3A5—blood—hematologic cancer	0.000123	0.00513	CbGeAlD
Progesterone—NR3C1—blood—hematologic cancer	0.000122	0.0051	CbGeAlD
Progesterone—CYP2C9—blood—hematologic cancer	0.000121	0.00505	CbGeAlD
Progesterone—NR3C1—bone marrow—hematologic cancer	0.000118	0.00493	CbGeAlD
Progesterone—SLC22A3—lymph node—hematologic cancer	0.000116	0.00485	CbGeAlD
Progesterone—Oxandrolone—AR—hematologic cancer	0.000116	0.0618	CrCbGaD
Progesterone—CYP2C8—testis—hematologic cancer	0.000113	0.00471	CbGeAlD
Progesterone—SIGMAR1—lymph node—hematologic cancer	0.000112	0.00468	CbGeAlD
Progesterone—CYP1A2—lung—hematologic cancer	0.000112	0.00467	CbGeAlD
Progesterone—CYP1A1—lung—hematologic cancer	0.000111	0.0046	CbGeAlD
Progesterone—CYP3A5—lung—hematologic cancer	0.000108	0.0045	CbGeAlD
Progesterone—NR3C1—lung—hematologic cancer	0.000107	0.00447	CbGeAlD
Progesterone—CYP1B1—lymph node—hematologic cancer	0.000107	0.00445	CbGeAlD
Progesterone—AR—lymph node—hematologic cancer	0.000101	0.00422	CbGeAlD
Progesterone—NR3C1—testis—hematologic cancer	0.000101	0.00421	CbGeAlD
Progesterone—ESR1—lymph node—hematologic cancer	9.94e-05	0.00414	CbGeAlD
Progesterone—ABCB1—hematopoietic system—hematologic cancer	9.88e-05	0.00412	CbGeAlD
Progesterone—ABCC1—lymph node—hematologic cancer	9.62e-05	0.00401	CbGeAlD
Progesterone—CYP3A4—blood—hematologic cancer	9.25e-05	0.00385	CbGeAlD
Progesterone—CYP2D6—blood—hematologic cancer	9.1e-05	0.00379	CbGeAlD
Progesterone—Nandrolone phenpropionate—AR—hematologic cancer	9.06e-05	0.0484	CrCbGaD
Progesterone—Danazol—CCL2—hematologic cancer	8.33e-05	0.0445	CrCbGaD
Progesterone—Drostanolone—AR—hematologic cancer	7.7e-05	0.0411	CrCbGaD
Progesterone—CYP1A1—lymph node—hematologic cancer	7.56e-05	0.00315	CbGeAlD
Progesterone—CYP2D6—testis—hematologic cancer	7.53e-05	0.00314	CbGeAlD
Progesterone—ABCB1—gonad—hematologic cancer	7.52e-05	0.00313	CbGeAlD
Progesterone—NR3C1—lymph node—hematologic cancer	7.33e-05	0.00306	CbGeAlD
Progesterone—Nandrolone decanoate—AR—hematologic cancer	6.86e-05	0.0367	CrCbGaD
Progesterone—Ethynodiol—ESR1—hematologic cancer	6.76e-05	0.0361	CrCbGaD
Progesterone—Testosterone Propionate—UGT1A1—hematologic cancer	6.57e-05	0.0351	CrCbGaD
Progesterone—ABCB1—blood—hematologic cancer	6.55e-05	0.00273	CbGeAlD
Progesterone—ABCB1—bone marrow—hematologic cancer	6.34e-05	0.00264	CbGeAlD
Progesterone—Trilostane—ESR1—hematologic cancer	6.22e-05	0.0332	CrCbGaD
Progesterone—Norgestimate—ESR1—hematologic cancer	5.75e-05	0.0307	CrCbGaD
Progesterone—ABCB1—lung—hematologic cancer	5.74e-05	0.00239	CbGeAlD
Progesterone—Drospirenone—AR—hematologic cancer	5.6e-05	0.0299	CrCbGaD
Progesterone—ABCB1—testis—hematologic cancer	5.42e-05	0.00226	CbGeAlD
Progesterone—Fludrocortisone—AR—hematologic cancer	5.27e-05	0.0282	CrCbGaD
Progesterone—Medrysone—NR3C1—hematologic cancer	4.91e-05	0.0262	CrCbGaD
Progesterone—Testosterone Propionate—AR—hematologic cancer	4.7e-05	0.0251	CrCbGaD
Progesterone—Hydrocortamate—NR3C1—hematologic cancer	4.58e-05	0.0245	CrCbGaD
Progesterone—Levonorgestrel—AR—hematologic cancer	4.57e-05	0.0244	CrCbGaD
Progesterone—Cortisone acetate—NR3C1—hematologic cancer	4.51e-05	0.0241	CrCbGaD
Progesterone—Fluoxymesterone—AR—hematologic cancer	4.35e-05	0.0233	CrCbGaD
Progesterone—Megestrol acetate—NR3C1—hematologic cancer	4.35e-05	0.0232	CrCbGaD
Progesterone—Danazol—AR—hematologic cancer	4.16e-05	0.0222	CrCbGaD
Progesterone—Spironolactone—AR—hematologic cancer	3.98e-05	0.0213	CrCbGaD
Progesterone—ABCB1—lymph node—hematologic cancer	3.93e-05	0.00164	CbGeAlD
Progesterone—Medroxyprogesterone Acetate—AR—hematologic cancer	3.73e-05	0.0199	CrCbGaD
Progesterone—Fludrocortisone—NR3C1—hematologic cancer	3.57e-05	0.0191	CrCbGaD
Progesterone—Levonorgestrel—ESR1—hematologic cancer	3.52e-05	0.0188	CrCbGaD
Progesterone—Methyltestosterone—AR—hematologic cancer	3.51e-05	0.0188	CrCbGaD
Progesterone—Fluoxymesterone—ESR1—hematologic cancer	3.35e-05	0.0179	CrCbGaD
Progesterone—Danazol—ESR1—hematologic cancer	3.2e-05	0.0171	CrCbGaD
Progesterone—Fluoxymesterone—NR3C1—hematologic cancer	2.95e-05	0.0158	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—ESR1—hematologic cancer	2.88e-05	0.0154	CrCbGaD
Progesterone—Spironolactone—NR3C1—hematologic cancer	2.7e-05	0.0144	CrCbGaD
Progesterone—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	2.53e-05	0.0135	CrCbGaD
Progesterone—Prednisolone—NR3C1—hematologic cancer	2.35e-05	0.0125	CrCbGaD
Progesterone—Testosterone—SLC22A1—hematologic cancer	2.29e-05	0.0123	CrCbGaD
Progesterone—Megestrol acetate—ABCB1—hematologic cancer	2.1e-05	0.0112	CrCbGaD
Progesterone—Hydrocortisone—ABCG2—hematologic cancer	2.08e-05	0.0111	CrCbGaD
Progesterone—Testosterone—AR—hematologic cancer	2.04e-05	0.0109	CrCbGaD
Progesterone—Hydrocortisone—NR3C1—hematologic cancer	1.79e-05	0.00959	CrCbGaD
Progesterone—Testosterone—ABCG2—hematologic cancer	1.6e-05	0.00856	CrCbGaD
Progesterone—Spironolactone—ABCB1—hematologic cancer	1.3e-05	0.00697	CrCbGaD
Progesterone—Norethindrone—ALB—hematologic cancer	1.27e-05	0.00678	CrCbGaD
Progesterone—Norethindrone—ABCB1—hematologic cancer	1.21e-05	0.00647	CrCbGaD
Progesterone—Methyltestosterone—ALB—hematologic cancer	1.21e-05	0.00644	CrCbGaD
Progesterone—Prednisolone—ABCB1—hematologic cancer	1.13e-05	0.00605	CrCbGaD
Progesterone—Hydrocortisone—ABCB1—hematologic cancer	8.66e-06	0.00463	CrCbGaD
Progesterone—Testosterone—ALB—hematologic cancer	6.99e-06	0.00373	CrCbGaD
Progesterone—Testosterone—ABCB1—hematologic cancer	6.67e-06	0.00356	CrCbGaD
Progesterone—Dermatitis—Cisplatin—hematologic cancer	6.06e-06	6.62e-05	CcSEcCtD
Progesterone—Erythema—Epirubicin—hematologic cancer	6.06e-06	6.61e-05	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—hematologic cancer	6.06e-06	6.61e-05	CcSEcCtD
Progesterone—Diarrhoea—Etoposide—hematologic cancer	6.03e-06	6.59e-05	CcSEcCtD
Progesterone—Anorexia—Prednisone—hematologic cancer	6.02e-06	6.58e-05	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—hematologic cancer	6.01e-06	6.57e-05	CcSEcCtD
Progesterone—Ill-defined disorder—Methotrexate—hematologic cancer	6e-06	6.55e-05	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—hematologic cancer	6e-06	6.55e-05	CcSEcCtD
Progesterone—Anaemia—Methotrexate—hematologic cancer	5.98e-06	6.53e-05	CcSEcCtD
Progesterone—Feeling abnormal—Betamethasone—hematologic cancer	5.98e-06	6.53e-05	CcSEcCtD
Progesterone—Feeling abnormal—Dexamethasone—hematologic cancer	5.98e-06	6.53e-05	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—hematologic cancer	5.97e-06	6.52e-05	CcSEcCtD
Progesterone—Flatulence—Epirubicin—hematologic cancer	5.97e-06	6.51e-05	CcSEcCtD
Progesterone—Tension—Epirubicin—hematologic cancer	5.94e-06	6.49e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.93e-06	6.48e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Betamethasone—hematologic cancer	5.93e-06	6.48e-05	CcSEcCtD
Progesterone—Hypersensitivity—Triamcinolone—hematologic cancer	5.89e-06	6.43e-05	CcSEcCtD
Progesterone—Nervousness—Epirubicin—hematologic cancer	5.88e-06	6.42e-05	CcSEcCtD
Progesterone—Back pain—Epirubicin—hematologic cancer	5.86e-06	6.39e-05	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—hematologic cancer	5.84e-06	6.38e-05	CcSEcCtD
Progesterone—Malaise—Methotrexate—hematologic cancer	5.84e-06	6.37e-05	CcSEcCtD
Progesterone—Dizziness—Etoposide—hematologic cancer	5.83e-06	6.37e-05	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—hematologic cancer	5.82e-06	6.36e-05	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—hematologic cancer	5.81e-06	6.35e-05	CcSEcCtD
Progesterone—Vertigo—Methotrexate—hematologic cancer	5.81e-06	6.35e-05	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—hematologic cancer	5.8e-06	6.33e-05	CcSEcCtD
Progesterone—Urticaria—Dexamethasone—hematologic cancer	5.76e-06	6.29e-05	CcSEcCtD
Progesterone—Urticaria—Betamethasone—hematologic cancer	5.76e-06	6.29e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.76e-06	6.29e-05	CcSEcCtD
Progesterone—Dizziness—Prednisolone—hematologic cancer	5.75e-06	6.28e-05	CcSEcCtD
Progesterone—Asthenia—Triamcinolone—hematologic cancer	5.74e-06	6.26e-05	CcSEcCtD
Progesterone—Abdominal pain—Betamethasone—hematologic cancer	5.74e-06	6.26e-05	CcSEcCtD
Progesterone—Body temperature increased—Dexamethasone—hematologic cancer	5.74e-06	6.26e-05	CcSEcCtD
Progesterone—Abdominal pain—Dexamethasone—hematologic cancer	5.74e-06	6.26e-05	CcSEcCtD
Progesterone—Body temperature increased—Betamethasone—hematologic cancer	5.74e-06	6.26e-05	CcSEcCtD
Progesterone—Nausea—Cisplatin—hematologic cancer	5.72e-06	6.24e-05	CcSEcCtD
Progesterone—Insomnia—Prednisone—hematologic cancer	5.72e-06	6.24e-05	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—hematologic cancer	5.71e-06	6.23e-05	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—hematologic cancer	5.69e-06	6.21e-05	CcSEcCtD
Progesterone—Paraesthesia—Prednisone—hematologic cancer	5.67e-06	6.19e-05	CcSEcCtD
Progesterone—Pruritus—Triamcinolone—hematologic cancer	5.66e-06	6.18e-05	CcSEcCtD
Progesterone—Cough—Methotrexate—hematologic cancer	5.65e-06	6.16e-05	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—hematologic cancer	5.64e-06	6.16e-05	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—hematologic cancer	5.62e-06	6.13e-05	CcSEcCtD
Progesterone—Convulsion—Methotrexate—hematologic cancer	5.61e-06	6.12e-05	CcSEcCtD
Progesterone—Vomiting—Etoposide—hematologic cancer	5.61e-06	6.12e-05	CcSEcCtD
Progesterone—Erythema—Doxorubicin—hematologic cancer	5.6e-06	6.12e-05	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—hematologic cancer	5.6e-06	6.12e-05	CcSEcCtD
Progesterone—Anaemia—Epirubicin—hematologic cancer	5.6e-06	6.11e-05	CcSEcCtD
Progesterone—Dyspepsia—Prednisone—hematologic cancer	5.56e-06	6.07e-05	CcSEcCtD
Progesterone—Rash—Etoposide—hematologic cancer	5.56e-06	6.07e-05	CcSEcCtD
Progesterone—Dermatitis—Etoposide—hematologic cancer	5.55e-06	6.06e-05	CcSEcCtD
Progesterone—Headache—Etoposide—hematologic cancer	5.52e-06	6.03e-05	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—hematologic cancer	5.52e-06	6.03e-05	CcSEcCtD
Progesterone—Chest pain—Methotrexate—hematologic cancer	5.51e-06	6.01e-05	CcSEcCtD
Progesterone—Arthralgia—Methotrexate—hematologic cancer	5.51e-06	6.01e-05	CcSEcCtD
Progesterone—Myalgia—Methotrexate—hematologic cancer	5.51e-06	6.01e-05	CcSEcCtD
Progesterone—Tension—Doxorubicin—hematologic cancer	5.5e-06	6e-05	CcSEcCtD
Progesterone—Decreased appetite—Prednisone—hematologic cancer	5.49e-06	6e-05	CcSEcCtD
Progesterone—Rash—Prednisolone—hematologic cancer	5.48e-06	5.99e-05	CcSEcCtD
Progesterone—Dermatitis—Prednisolone—hematologic cancer	5.48e-06	5.98e-05	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.47e-06	5.97e-05	CcSEcCtD
Progesterone—Malaise—Epirubicin—hematologic cancer	5.46e-06	5.96e-05	CcSEcCtD
Progesterone—Fatigue—Prednisone—hematologic cancer	5.45e-06	5.95e-05	CcSEcCtD
Progesterone—Headache—Prednisolone—hematologic cancer	5.45e-06	5.95e-05	CcSEcCtD
Progesterone—Discomfort—Methotrexate—hematologic cancer	5.44e-06	5.94e-05	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—hematologic cancer	5.44e-06	5.94e-05	CcSEcCtD
Progesterone—Vertigo—Epirubicin—hematologic cancer	5.44e-06	5.94e-05	CcSEcCtD
Progesterone—Syncope—Epirubicin—hematologic cancer	5.43e-06	5.93e-05	CcSEcCtD
Progesterone—Back pain—Doxorubicin—hematologic cancer	5.42e-06	5.92e-05	CcSEcCtD
Progesterone—Constipation—Prednisone—hematologic cancer	5.4e-06	5.9e-05	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—hematologic cancer	5.39e-06	5.88e-05	CcSEcCtD
Progesterone—Palpitations—Epirubicin—hematologic cancer	5.35e-06	5.84e-05	CcSEcCtD
Progesterone—Confusional state—Methotrexate—hematologic cancer	5.32e-06	5.81e-05	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—hematologic cancer	5.32e-06	5.81e-05	CcSEcCtD
Progesterone—Dizziness—Triamcinolone—hematologic cancer	5.29e-06	5.77e-05	CcSEcCtD
Progesterone—Cough—Epirubicin—hematologic cancer	5.28e-06	5.77e-05	CcSEcCtD
Progesterone—Anaphylactic shock—Methotrexate—hematologic cancer	5.28e-06	5.77e-05	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—hematologic cancer	5.28e-06	5.76e-05	CcSEcCtD
Progesterone—Convulsion—Epirubicin—hematologic cancer	5.25e-06	5.73e-05	CcSEcCtD
Progesterone—Infection—Methotrexate—hematologic cancer	5.25e-06	5.73e-05	CcSEcCtD
Progesterone—Nausea—Etoposide—hematologic cancer	5.24e-06	5.72e-05	CcSEcCtD
Progesterone—Hypertension—Epirubicin—hematologic cancer	5.23e-06	5.71e-05	CcSEcCtD
Progesterone—Feeling abnormal—Prednisone—hematologic cancer	5.21e-06	5.68e-05	CcSEcCtD
Progesterone—Asthenia—Betamethasone—hematologic cancer	5.21e-06	5.68e-05	CcSEcCtD
Progesterone—Asthenia—Dexamethasone—hematologic cancer	5.21e-06	5.68e-05	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—hematologic cancer	5.2e-06	5.68e-05	CcSEcCtD
Progesterone—Nervous system disorder—Methotrexate—hematologic cancer	5.18e-06	5.65e-05	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—hematologic cancer	5.18e-06	5.65e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Prednisone—hematologic cancer	5.17e-06	5.64e-05	CcSEcCtD
Progesterone—Nausea—Prednisolone—hematologic cancer	5.17e-06	5.64e-05	CcSEcCtD
Progesterone—Chest pain—Epirubicin—hematologic cancer	5.16e-06	5.63e-05	CcSEcCtD
Progesterone—Myalgia—Epirubicin—hematologic cancer	5.16e-06	5.63e-05	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—hematologic cancer	5.16e-06	5.63e-05	CcSEcCtD
Progesterone—Anxiety—Epirubicin—hematologic cancer	5.14e-06	5.61e-05	CcSEcCtD
Progesterone—Pruritus—Dexamethasone—hematologic cancer	5.13e-06	5.6e-05	CcSEcCtD
Progesterone—Pruritus—Betamethasone—hematologic cancer	5.13e-06	5.6e-05	CcSEcCtD
Progesterone—Skin disorder—Methotrexate—hematologic cancer	5.13e-06	5.6e-05	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.12e-06	5.59e-05	CcSEcCtD
Progesterone—Hyperhidrosis—Methotrexate—hematologic cancer	5.11e-06	5.57e-05	CcSEcCtD
Progesterone—Discomfort—Epirubicin—hematologic cancer	5.09e-06	5.56e-05	CcSEcCtD
Progesterone—Vomiting—Triamcinolone—hematologic cancer	5.08e-06	5.55e-05	CcSEcCtD
Progesterone—Malaise—Doxorubicin—hematologic cancer	5.05e-06	5.52e-05	CcSEcCtD
Progesterone—Rash—Triamcinolone—hematologic cancer	5.04e-06	5.5e-05	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—hematologic cancer	5.04e-06	5.5e-05	CcSEcCtD
Progesterone—Dermatitis—Triamcinolone—hematologic cancer	5.04e-06	5.5e-05	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—hematologic cancer	5.03e-06	5.5e-05	CcSEcCtD
Progesterone—Anorexia—Methotrexate—hematologic cancer	5.03e-06	5.5e-05	CcSEcCtD
Progesterone—Syncope—Doxorubicin—hematologic cancer	5.02e-06	5.49e-05	CcSEcCtD
Progesterone—Urticaria—Prednisone—hematologic cancer	5.02e-06	5.48e-05	CcSEcCtD
Progesterone—Headache—Triamcinolone—hematologic cancer	5.01e-06	5.47e-05	CcSEcCtD
Progesterone—Abdominal pain—Prednisone—hematologic cancer	5e-06	5.45e-05	CcSEcCtD
Progesterone—Body temperature increased—Prednisone—hematologic cancer	5e-06	5.45e-05	CcSEcCtD
Progesterone—Confusional state—Epirubicin—hematologic cancer	4.98e-06	5.44e-05	CcSEcCtD
Progesterone—Diarrhoea—Betamethasone—hematologic cancer	4.96e-06	5.42e-05	CcSEcCtD
Progesterone—Diarrhoea—Dexamethasone—hematologic cancer	4.96e-06	5.42e-05	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—hematologic cancer	4.95e-06	5.41e-05	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—hematologic cancer	4.94e-06	5.4e-05	CcSEcCtD
Progesterone—Oedema—Epirubicin—hematologic cancer	4.94e-06	5.4e-05	CcSEcCtD
Progesterone—Hypotension—Methotrexate—hematologic cancer	4.93e-06	5.39e-05	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—hematologic cancer	4.92e-06	5.38e-05	CcSEcCtD
Progesterone—Infection—Epirubicin—hematologic cancer	4.91e-06	5.36e-05	CcSEcCtD
Progesterone—Cough—Doxorubicin—hematologic cancer	4.89e-06	5.34e-05	CcSEcCtD
Progesterone—Shock—Epirubicin—hematologic cancer	4.86e-06	5.31e-05	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—hematologic cancer	4.85e-06	5.3e-05	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—hematologic cancer	4.85e-06	5.29e-05	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—hematologic cancer	4.84e-06	5.28e-05	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—hematologic cancer	4.82e-06	5.27e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.81e-06	5.25e-05	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—hematologic cancer	4.8e-06	5.24e-05	CcSEcCtD
Progesterone—Dizziness—Betamethasone—hematologic cancer	4.8e-06	5.24e-05	CcSEcCtD
Progesterone—Dizziness—Dexamethasone—hematologic cancer	4.8e-06	5.24e-05	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—hematologic cancer	4.78e-06	5.22e-05	CcSEcCtD
Progesterone—Insomnia—Methotrexate—hematologic cancer	4.78e-06	5.21e-05	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—hematologic cancer	4.77e-06	5.21e-05	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—hematologic cancer	4.77e-06	5.21e-05	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—hematologic cancer	4.77e-06	5.21e-05	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—hematologic cancer	4.75e-06	5.19e-05	CcSEcCtD
Progesterone—Nausea—Triamcinolone—hematologic cancer	4.75e-06	5.19e-05	CcSEcCtD
Progesterone—Paraesthesia—Methotrexate—hematologic cancer	4.74e-06	5.18e-05	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.74e-06	5.17e-05	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—hematologic cancer	4.71e-06	5.15e-05	CcSEcCtD
Progesterone—Anorexia—Epirubicin—hematologic cancer	4.71e-06	5.14e-05	CcSEcCtD
Progesterone—Dyspnoea—Methotrexate—hematologic cancer	4.71e-06	5.14e-05	CcSEcCtD
Progesterone—Somnolence—Methotrexate—hematologic cancer	4.69e-06	5.13e-05	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—hematologic cancer	4.67e-06	5.09e-05	CcSEcCtD
Progesterone—Hypersensitivity—Prednisone—hematologic cancer	4.66e-06	5.08e-05	CcSEcCtD
Progesterone—Dyspepsia—Methotrexate—hematologic cancer	4.65e-06	5.08e-05	CcSEcCtD
Progesterone—Hypotension—Epirubicin—hematologic cancer	4.62e-06	5.04e-05	CcSEcCtD
Progesterone—Vomiting—Betamethasone—hematologic cancer	4.61e-06	5.04e-05	CcSEcCtD
Progesterone—Vomiting—Dexamethasone—hematologic cancer	4.61e-06	5.04e-05	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—hematologic cancer	4.61e-06	5.03e-05	CcSEcCtD
Progesterone—Decreased appetite—Methotrexate—hematologic cancer	4.59e-06	5.01e-05	CcSEcCtD
Progesterone—Rash—Betamethasone—hematologic cancer	4.57e-06	4.99e-05	CcSEcCtD
Progesterone—Rash—Dexamethasone—hematologic cancer	4.57e-06	4.99e-05	CcSEcCtD
Progesterone—Oedema—Doxorubicin—hematologic cancer	4.57e-06	4.99e-05	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—hematologic cancer	4.57e-06	4.99e-05	CcSEcCtD
Progesterone—Dermatitis—Dexamethasone—hematologic cancer	4.57e-06	4.99e-05	CcSEcCtD
Progesterone—Dermatitis—Betamethasone—hematologic cancer	4.57e-06	4.99e-05	CcSEcCtD
Progesterone—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.56e-06	4.98e-05	CcSEcCtD
Progesterone—Fatigue—Methotrexate—hematologic cancer	4.55e-06	4.97e-05	CcSEcCtD
Progesterone—Headache—Dexamethasone—hematologic cancer	4.55e-06	4.96e-05	CcSEcCtD
Progesterone—Headache—Betamethasone—hematologic cancer	4.55e-06	4.96e-05	CcSEcCtD
Progesterone—Infection—Doxorubicin—hematologic cancer	4.54e-06	4.96e-05	CcSEcCtD
Progesterone—Asthenia—Prednisone—hematologic cancer	4.53e-06	4.95e-05	CcSEcCtD
Progesterone—Pain—Methotrexate—hematologic cancer	4.52e-06	4.93e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.5e-06	4.92e-05	CcSEcCtD
Progesterone—Shock—Doxorubicin—hematologic cancer	4.5e-06	4.91e-05	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—hematologic cancer	4.48e-06	4.9e-05	CcSEcCtD
Progesterone—Pruritus—Prednisone—hematologic cancer	4.47e-06	4.88e-05	CcSEcCtD
Progesterone—Insomnia—Epirubicin—hematologic cancer	4.47e-06	4.88e-05	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—hematologic cancer	4.46e-06	4.87e-05	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—hematologic cancer	4.44e-06	4.85e-05	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—hematologic cancer	4.44e-06	4.84e-05	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—hematologic cancer	4.42e-06	4.83e-05	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—hematologic cancer	4.41e-06	4.81e-05	CcSEcCtD
Progesterone—Somnolence—Epirubicin—hematologic cancer	4.39e-06	4.8e-05	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—hematologic cancer	4.36e-06	4.76e-05	CcSEcCtD
Progesterone—Feeling abnormal—Methotrexate—hematologic cancer	4.35e-06	4.75e-05	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—hematologic cancer	4.35e-06	4.75e-05	CcSEcCtD
Progesterone—Diarrhoea—Prednisone—hematologic cancer	4.32e-06	4.72e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Methotrexate—hematologic cancer	4.32e-06	4.71e-05	CcSEcCtD
Progesterone—Nausea—Betamethasone—hematologic cancer	4.31e-06	4.71e-05	CcSEcCtD
Progesterone—Nausea—Dexamethasone—hematologic cancer	4.31e-06	4.71e-05	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—hematologic cancer	4.3e-06	4.69e-05	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—hematologic cancer	4.27e-06	4.67e-05	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.27e-06	4.66e-05	CcSEcCtD
Progesterone—Fatigue—Epirubicin—hematologic cancer	4.26e-06	4.65e-05	CcSEcCtD
Progesterone—Pain—Epirubicin—hematologic cancer	4.23e-06	4.61e-05	CcSEcCtD
Progesterone—Constipation—Epirubicin—hematologic cancer	4.23e-06	4.61e-05	CcSEcCtD
Progesterone—Urticaria—Methotrexate—hematologic cancer	4.2e-06	4.58e-05	CcSEcCtD
Progesterone—Dizziness—Prednisone—hematologic cancer	4.18e-06	4.56e-05	CcSEcCtD
Progesterone—Abdominal pain—Methotrexate—hematologic cancer	4.17e-06	4.56e-05	CcSEcCtD
Progesterone—Body temperature increased—Methotrexate—hematologic cancer	4.17e-06	4.56e-05	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.17e-06	4.55e-05	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—hematologic cancer	4.14e-06	4.52e-05	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—hematologic cancer	4.11e-06	4.48e-05	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—hematologic cancer	4.08e-06	4.45e-05	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—hematologic cancer	4.07e-06	4.45e-05	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—hematologic cancer	4.07e-06	4.44e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—hematologic cancer	4.04e-06	4.41e-05	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—hematologic cancer	4.03e-06	4.39e-05	CcSEcCtD
Progesterone—Vomiting—Prednisone—hematologic cancer	4.02e-06	4.39e-05	CcSEcCtD
Progesterone—Rash—Prednisone—hematologic cancer	3.98e-06	4.35e-05	CcSEcCtD
Progesterone—Dermatitis—Prednisone—hematologic cancer	3.98e-06	4.35e-05	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—hematologic cancer	3.98e-06	4.34e-05	CcSEcCtD
Progesterone—Headache—Prednisone—hematologic cancer	3.96e-06	4.32e-05	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.95e-06	4.31e-05	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—hematologic cancer	3.94e-06	4.3e-05	CcSEcCtD
Progesterone—Urticaria—Epirubicin—hematologic cancer	3.93e-06	4.29e-05	CcSEcCtD
Progesterone—Constipation—Doxorubicin—hematologic cancer	3.91e-06	4.27e-05	CcSEcCtD
Progesterone—Pain—Doxorubicin—hematologic cancer	3.91e-06	4.27e-05	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—hematologic cancer	3.91e-06	4.27e-05	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—hematologic cancer	3.91e-06	4.27e-05	CcSEcCtD
Progesterone—Hypersensitivity—Methotrexate—hematologic cancer	3.89e-06	4.25e-05	CcSEcCtD
Progesterone—Asthenia—Methotrexate—hematologic cancer	3.79e-06	4.14e-05	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—hematologic cancer	3.77e-06	4.11e-05	CcSEcCtD
Progesterone—Nausea—Prednisone—hematologic cancer	3.75e-06	4.1e-05	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.74e-06	4.08e-05	CcSEcCtD
Progesterone—Pruritus—Methotrexate—hematologic cancer	3.74e-06	4.08e-05	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—hematologic cancer	3.64e-06	3.98e-05	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—hematologic cancer	3.63e-06	3.97e-05	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—hematologic cancer	3.61e-06	3.95e-05	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—hematologic cancer	3.61e-06	3.95e-05	CcSEcCtD
Progesterone—Diarrhoea—Methotrexate—hematologic cancer	3.61e-06	3.94e-05	CcSEcCtD
Progesterone—Asthenia—Epirubicin—hematologic cancer	3.55e-06	3.87e-05	CcSEcCtD
Progesterone—Pruritus—Epirubicin—hematologic cancer	3.5e-06	3.82e-05	CcSEcCtD
Progesterone—Dizziness—Methotrexate—hematologic cancer	3.49e-06	3.81e-05	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—hematologic cancer	3.38e-06	3.69e-05	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—hematologic cancer	3.37e-06	3.68e-05	CcSEcCtD
Progesterone—Vomiting—Methotrexate—hematologic cancer	3.36e-06	3.67e-05	CcSEcCtD
Progesterone—Rash—Methotrexate—hematologic cancer	3.33e-06	3.64e-05	CcSEcCtD
Progesterone—Dermatitis—Methotrexate—hematologic cancer	3.33e-06	3.63e-05	CcSEcCtD
Progesterone—Headache—Methotrexate—hematologic cancer	3.31e-06	3.61e-05	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—hematologic cancer	3.28e-06	3.58e-05	CcSEcCtD
Progesterone—Dizziness—Epirubicin—hematologic cancer	3.27e-06	3.57e-05	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—hematologic cancer	3.24e-06	3.53e-05	CcSEcCtD
Progesterone—Vomiting—Epirubicin—hematologic cancer	3.14e-06	3.43e-05	CcSEcCtD
Progesterone—Nausea—Methotrexate—hematologic cancer	3.14e-06	3.42e-05	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—hematologic cancer	3.13e-06	3.42e-05	CcSEcCtD
Progesterone—Rash—Epirubicin—hematologic cancer	3.12e-06	3.4e-05	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—hematologic cancer	3.11e-06	3.4e-05	CcSEcCtD
Progesterone—Headache—Epirubicin—hematologic cancer	3.1e-06	3.38e-05	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—hematologic cancer	3.02e-06	3.3e-05	CcSEcCtD
Progesterone—Nausea—Epirubicin—hematologic cancer	2.94e-06	3.2e-05	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—hematologic cancer	2.91e-06	3.17e-05	CcSEcCtD
Progesterone—Rash—Doxorubicin—hematologic cancer	2.88e-06	3.15e-05	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—hematologic cancer	2.88e-06	3.14e-05	CcSEcCtD
Progesterone—Headache—Doxorubicin—hematologic cancer	2.86e-06	3.13e-05	CcSEcCtD
Progesterone—Nausea—Doxorubicin—hematologic cancer	2.72e-06	2.97e-05	CcSEcCtD
Progesterone—OPRK1—Signaling Pathways—CCND1—hematologic cancer	6.99e-07	1.53e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—JUN—hematologic cancer	6.97e-07	1.53e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.86e-07	1.51e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MAPK3—hematologic cancer	6.86e-07	1.5e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3R1—hematologic cancer	6.84e-07	1.5e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.8e-07	1.49e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.8e-07	1.49e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	6.78e-07	1.49e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NQO1—hematologic cancer	6.77e-07	1.49e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CD44—hematologic cancer	6.77e-07	1.49e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CB—hematologic cancer	6.77e-07	1.49e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	6.76e-07	1.48e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	6.75e-07	1.48e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NUP214—hematologic cancer	6.75e-07	1.48e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—hematologic cancer	6.74e-07	1.48e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3R1—hematologic cancer	6.74e-07	1.48e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—hematologic cancer	6.72e-07	1.47e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	6.71e-07	1.47e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.71e-07	1.47e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—hematologic cancer	6.67e-07	1.46e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTP1—hematologic cancer	6.67e-07	1.46e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—GSTM1—hematologic cancer	6.66e-07	1.46e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NCOR1—hematologic cancer	6.66e-07	1.46e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—TGFB1—hematologic cancer	6.65e-07	1.46e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MAPK3—hematologic cancer	6.64e-07	1.46e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.63e-07	1.45e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.61e-07	1.45e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MTR—hematologic cancer	6.61e-07	1.45e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—hematologic cancer	6.61e-07	1.45e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.61e-07	1.45e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—MTHFR—hematologic cancer	6.6e-07	1.45e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	6.6e-07	1.45e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—hematologic cancer	6.58e-07	1.44e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	6.58e-07	1.44e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MAPK3—hematologic cancer	6.54e-07	1.43e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—GSTM1—hematologic cancer	6.5e-07	1.43e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NCOR1—hematologic cancer	6.5e-07	1.43e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—hematologic cancer	6.5e-07	1.43e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—hematologic cancer	6.49e-07	1.42e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—hematologic cancer	6.46e-07	1.42e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EP300—hematologic cancer	6.43e-07	1.41e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FGF2—hematologic cancer	6.42e-07	1.41e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—hematologic cancer	6.42e-07	1.41e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—EP300—hematologic cancer	6.41e-07	1.41e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYCS—hematologic cancer	6.41e-07	1.41e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	6.4e-07	1.4e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.4e-07	1.4e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	6.37e-07	1.4e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—hematologic cancer	6.36e-07	1.39e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.34e-07	1.39e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	6.34e-07	1.39e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CB—hematologic cancer	6.31e-07	1.38e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.31e-07	1.38e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—hematologic cancer	6.31e-07	1.38e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.29e-07	1.38e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.26e-07	1.37e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SRC—hematologic cancer	6.25e-07	1.37e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CB—hematologic cancer	6.22e-07	1.36e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—EP300—hematologic cancer	6.2e-07	1.36e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—hematologic cancer	6.16e-07	1.35e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JAK2—hematologic cancer	6.16e-07	1.35e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SDC1—hematologic cancer	6.15e-07	1.35e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NCOR1—hematologic cancer	6.13e-07	1.34e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—GSTM1—hematologic cancer	6.13e-07	1.34e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	6.09e-07	1.34e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NCOR1—hematologic cancer	6.08e-07	1.33e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—GSTM1—hematologic cancer	6.08e-07	1.33e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—hematologic cancer	6.07e-07	1.33e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CG—hematologic cancer	6.05e-07	1.33e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—hematologic cancer	6.03e-07	1.32e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—hematologic cancer	6.02e-07	1.32e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MDM2—hematologic cancer	6.01e-07	1.32e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CREBBP—hematologic cancer	5.93e-07	1.3e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.89e-07	1.29e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—hematologic cancer	5.88e-07	1.29e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—hematologic cancer	5.86e-07	1.29e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—hematologic cancer	5.85e-07	1.28e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MTOR—hematologic cancer	5.85e-07	1.28e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	5.85e-07	1.28e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—hematologic cancer	5.81e-07	1.27e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.81e-07	1.27e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	5.76e-07	1.26e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—MTHFR—hematologic cancer	5.75e-07	1.26e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.73e-07	1.26e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—hematologic cancer	5.66e-07	1.24e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTP1—hematologic cancer	5.65e-07	1.24e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	5.63e-07	1.23e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—hematologic cancer	5.62e-07	1.23e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CREBBP—hematologic cancer	5.61e-07	1.23e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—hematologic cancer	5.6e-07	1.23e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—EP300—hematologic cancer	5.59e-07	1.23e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	5.59e-07	1.23e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—EP300—hematologic cancer	5.58e-07	1.22e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ALB—hematologic cancer	5.55e-07	1.22e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	5.54e-07	1.22e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	5.49e-07	1.2e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.47e-07	1.2e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—hematologic cancer	5.46e-07	1.2e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.42e-07	1.19e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—hematologic cancer	5.38e-07	1.18e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—hematologic cancer	5.38e-07	1.18e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—hematologic cancer	5.38e-07	1.18e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—hematologic cancer	5.37e-07	1.18e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL2—hematologic cancer	5.37e-07	1.18e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.37e-07	1.18e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ABCB1—hematologic cancer	5.35e-07	1.17e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CD—hematologic cancer	5.32e-07	1.17e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	5.31e-07	1.16e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ALB—hematologic cancer	5.25e-07	1.15e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—hematologic cancer	5.24e-07	1.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—hematologic cancer	5.24e-07	1.15e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NQO1—hematologic cancer	5.23e-07	1.15e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CD44—hematologic cancer	5.23e-07	1.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JUN—hematologic cancer	5.22e-07	1.15e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—EP300—hematologic cancer	5.2e-07	1.14e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NCOR1—hematologic cancer	5.19e-07	1.14e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—GSTM1—hematologic cancer	5.19e-07	1.14e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.19e-07	1.14e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—hematologic cancer	5.18e-07	1.14e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—hematologic cancer	5.16e-07	1.13e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CREBBP—hematologic cancer	5.14e-07	1.13e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—EP300—hematologic cancer	5.12e-07	1.12e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	5.06e-07	1.11e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—hematologic cancer	5.05e-07	1.11e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3R1—hematologic cancer	5.02e-07	1.1e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—hematologic cancer	5.01e-07	1.1e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—hematologic cancer	4.96e-07	1.09e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.95e-07	1.08e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYCS—hematologic cancer	4.95e-07	1.08e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK8—hematologic cancer	4.94e-07	1.08e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.92e-07	1.08e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	4.9e-07	1.08e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	4.87e-07	1.07e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.83e-07	1.06e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EP300—hematologic cancer	4.82e-07	1.06e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ALB—hematologic cancer	4.81e-07	1.05e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	4.76e-07	1.04e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—hematologic cancer	4.74e-07	1.04e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.73e-07	1.04e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SRC—hematologic cancer	4.69e-07	1.03e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CB—hematologic cancer	4.63e-07	1.02e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—hematologic cancer	4.63e-07	1.01e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—hematologic cancer	4.6e-07	1.01e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	4.6e-07	1.01e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.59e-07	1.01e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.59e-07	1.01e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—hematologic cancer	4.59e-07	1.01e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—hematologic cancer	4.56e-07	1e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.55e-07	9.98e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—hematologic cancer	4.52e-07	9.91e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.51e-07	9.89e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—hematologic cancer	4.51e-07	9.89e-06	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—hematologic cancer	4.48e-07	9.82e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CREBBP—hematologic cancer	4.48e-07	9.82e-06	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—hematologic cancer	4.41e-07	9.67e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—hematologic cancer	4.4e-07	9.65e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.36e-07	9.56e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4.35e-07	9.54e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MAPK3—hematologic cancer	4.32e-07	9.47e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ALB—hematologic cancer	4.29e-07	9.42e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	4.25e-07	9.31e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.25e-07	9.31e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—hematologic cancer	4.24e-07	9.29e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.22e-07	9.25e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—hematologic cancer	4.21e-07	9.24e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—hematologic cancer	4.2e-07	9.21e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ALB—hematologic cancer	4.19e-07	9.19e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TGFB1—hematologic cancer	4.19e-07	9.19e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.18e-07	9.17e-06	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	4.14e-07	9.07e-06	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—hematologic cancer	4.13e-07	9.05e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.13e-07	9.05e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	4.11e-07	9.01e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.04e-07	8.87e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—EP300—hematologic cancer	4.04e-07	8.86e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3R1—hematologic cancer	4.01e-07	8.79e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.01e-07	8.79e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.01e-07	8.79e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—hematologic cancer	4e-07	8.78e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4e-07	8.77e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.97e-07	8.7e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ALB—hematologic cancer	3.95e-07	8.66e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ALB—hematologic cancer	3.92e-07	8.58e-06	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—hematologic cancer	3.89e-07	8.52e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—hematologic cancer	3.88e-07	8.51e-06	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—hematologic cancer	3.87e-07	8.49e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.86e-07	8.45e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—hematologic cancer	3.85e-07	8.44e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—EP300—hematologic cancer	3.82e-07	8.37e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.79e-07	8.31e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—hematologic cancer	3.79e-07	8.31e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.78e-07	8.28e-06	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—hematologic cancer	3.75e-07	8.21e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.74e-07	8.21e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.7e-07	8.11e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—hematologic cancer	3.67e-07	8.05e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.57e-07	7.84e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	3.56e-07	7.82e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.54e-07	7.76e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—EP300—hematologic cancer	3.5e-07	7.67e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.49e-07	7.65e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.46e-07	7.58e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—hematologic cancer	3.45e-07	7.56e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.39e-07	7.43e-06	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—hematologic cancer	3.38e-07	7.41e-06	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—hematologic cancer	3.37e-07	7.4e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ALB—hematologic cancer	3.35e-07	7.34e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—hematologic cancer	3.3e-07	7.23e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—hematologic cancer	3.28e-07	7.18e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	3.2e-07	7.02e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—hematologic cancer	3.2e-07	7.01e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—hematologic cancer	3.16e-07	6.92e-06	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—hematologic cancer	3.14e-07	6.89e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—EP300—hematologic cancer	3.12e-07	6.85e-06	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—hematologic cancer	3.1e-07	6.79e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—EP300—hematologic cancer	3.05e-07	6.69e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—hematologic cancer	3.01e-07	6.61e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.99e-07	6.55e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—hematologic cancer	2.99e-07	6.55e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.98e-07	6.52e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.95e-07	6.48e-06	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—hematologic cancer	2.91e-07	6.39e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—EP300—hematologic cancer	2.87e-07	6.3e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—EP300—hematologic cancer	2.85e-07	6.25e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—hematologic cancer	2.82e-07	6.19e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.76e-07	6.05e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.62e-07	5.74e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	2.59e-07	5.68e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ALB—hematologic cancer	2.58e-07	5.66e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—hematologic cancer	2.55e-07	5.6e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.47e-07	5.42e-06	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—hematologic cancer	2.44e-07	5.35e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—EP300—hematologic cancer	2.43e-07	5.34e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.31e-07	5.07e-06	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—hematologic cancer	2.31e-07	5.06e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.28e-07	5e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.26e-07	4.95e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.13e-07	4.66e-06	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—hematologic cancer	2.12e-07	4.64e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.11e-07	4.62e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.97e-07	4.32e-06	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—hematologic cancer	1.89e-07	4.14e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—EP300—hematologic cancer	1.88e-07	4.12e-06	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—hematologic cancer	1.84e-07	4.04e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.8e-07	3.95e-06	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—hematologic cancer	1.74e-07	3.81e-06	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—hematologic cancer	1.72e-07	3.77e-06	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—hematologic cancer	1.47e-07	3.23e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.39e-07	3.05e-06	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.14e-07	2.49e-06	CbGpPWpGaD
